Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jan;8(1):3-5.
doi: 10.1111/jdi.12521. Epub 2016 May 11.

Continuous glucose monitoring in China: Then, now and in the future

Weiping Jia  1
Affiliations
Editorial

Continuous glucose monitoring in China: Then, now and in the future

Weiping Jia. J Diabetes Investig. 2017 Jan.

Abstract

Glucose monitoring is a key component in assessing glucose metabolic disturbance, evaluating therapeutic outcomes and guiding treatment regimens. For decades, continuous glucose monitoring (CGM) was one of the dreams of patients with diabetes and diabetologists. In this article, the research progress, opportunities and challenges of the use of CGM technology are reviewed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Continuous glucose‐monitoring tracings for 3 days (each day in a different color) in (a) a type 2 diabetic patient and (b) a participant with normal glucose regulation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Zhou J, Li H, Ran X, et al Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 2009; 32: 1188–1193. - PMC - PubMed
    1. Chinese Diabetes Society . Chinese clinical guideline for continuous glucose monitoring (2012). Chin Med J 2012; 125: 4167–4174. - PubMed
    1. Bao YQ, Zhou J, Zhou M, et al Glipizide controlled‐release tablets with or without acarbose improves glycemic variability in newly diagnosed type 2 diabetes. Clin Exp Pharmacol Physiol 2010; 37: 564–568. - PubMed
    1. Zhou J, Li H, Zhang X, et al Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in Chinese antihyperglycemic agent‐naive subjects with type 2 diabetes. Diabetes Technol Ther 2013; 15: 481–488. - PMC - PubMed
    1. Zhou J, Li H, Ran X, et al Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit 2011; 17: CR 9–13. - PMC - PubMed

Publication types

MeSH terms